Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$449.1M
15M shares
52-week range
$17.31 – $34.20
75% from low
Sector
DAIRY PRODUCTS
Exchange
NASDAQ
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $103.3M | $93.7M | $102.0M | $119.1M | $141.6M | $160.1M | $186.8M | $212.5M |
| Cost of revenue | $77.5M | $71.5M | $75.1M | $90.4M | $114.8M | $117.7M | $138.2M | $154.3M |
| Gross profit | $25.9M | $22.1M | $26.9M | $28.7M | $26.8M | $42.4M | $48.6M | $58.2M |
| Gross margin | 25.0% | 23.6% | 26.4% | 24.1% | 18.9% | 26.5% | 26.0% | 27.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$3.1M | −$1.9M | $4.9M | $5.9M | $2.3M | $17.0M | $13.9M | $16.2M |
| EBITDA | $437.0K | $4.8M | $8.2M | $8.6M | $5.1M | $20.2M | $17.5M | $23.7M |
| Net income | −$3.1M | $453.0K | $3.2M | $3.3M | $924.0K | $11.4M | $9.0M | $13.9M |
| Net margin | -3.0% | 0.5% | 3.2% | 2.8% | 0.7% | 7.1% | 4.8% | 6.5% |
| EPS (diluted) | -0.19 | 0.03 | 0.21 | 0.21 | 0.06 | 0.75 | 0.59 | 0.89 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $252M | $1.11 | $1.01–$1.21 | 2 |
| 2027 | $285M | $1.48 | $1.43–$1.53 | 2 |
| 2028 | $310M | $1.62 | $1.61–$1.63 | 1 |
| 2029 | $331M | $1.88 | $1.86–$1.90 | 1 |
Forward consensus · source: Financial Modeling Prep
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
www.lifewaykefir.comNo one on the platform currently holds LWAY.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 368,671 | $7.1M |
| Execution date | Ratio |
|---|---|
| 2006-08-16 | 2-for-1 |
| 2004-03-09 | 2-for-1 |
No one on the platform has traded LWAY yet.
| $416M |
| — |
| LNDBrasilAgro - Companhia Brasileira de Propriedades Agrícolas | $3.60 | +0.84% | $359M | — |
| MAMAMama's Creations, Inc. | $20.65 | +3.56% | $841M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 44.1× earnings vs its 27.8× historical median P/E.
Fair value ≈ $18.88 · price $29.92 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$RGEN this a Buffett, Lynch, anyone with a brain stock. i mean $LWAY dominates their market but its just not the comparison that you wanna do. nothing wrong with lifeway but its more proprietary to sybthesize protein A
View on StockTwits ↗#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
View on StockTwits ↗$LWAY presented its 2026 annual meeting results, with shareholders ratifying Grant Thornton as auditor.
View on StockTwits ↗$LWAY terminated its poison pill, ending the shareholder rights plan.
View on StockTwits ↗$LWAY redeemed its preferred share purchase rights at $0.001 each, terminating the rights agreement.
View on StockTwits ↗$LWAY 10%er action here Divisadero Street Partners, L.P. (10%+) purchased 165,045 shares at an average price of $25.45 (Form 4).
View on StockTwits ↗$LWAY bought back what I sold ahead of the ER. And for grins put in a GTC Buy at $20.00 for a lot more than I bought just now. It won't happen; but if any were sold it would be some weird, lottery level like event. need a really hard selling day in the market for LWAY to take hit.
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-5-14-lifeway-foods-inc-stock/ $LWAY Lifeway Foods Earnings Transcript
View on StockTwits ↗$LWAY Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.31 up 34.78% YoY • Reported revenue of $63.01M up 36.71% YoY
View on StockTwits ↗$LWAY 🚀 Earnings Thursday pre-market They already pre-announced Q1 revenue of $60.8M–$62.3M — that's 32–35% YoY growth in a packaged food stock. Kefir and probiotics aren't a fad, the gut health trend is only getting bigger. Last quarter's miss was on margins, not demand. If they show any cost discipline Thursday, this thing could pop. Analyst price target is $35 vs ~$26 today — plenty of room to pop
View on StockTwits ↗$LWAY partnered with Erewhon to launch a Tropical Lifeway Smoothie built around its organic kefir, so this is mainly a branded retail product-placement win.
View on StockTwits ↗$LWAY family dynamic here is interesting...this is exciting lol
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.